Lanean...
Amrubicin is effective against small cell carcinoma of the prostate as a second‐line chemotherapeutic agent: A case report
INTRODUCTION: Small cell carcinoma of the prostate has a poor prognosis. Furthermore, treatments for small cell carcinoma of the prostate have not been established. We report a case where amrubicin was effective for second‐line chemotherapy. CASE PRESENTATION: A 50‐year‐old man complaining of painfu...
Gorde:
| Argitaratua izan da: | IJU Case Rep |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292199/ https://ncbi.nlm.nih.gov/pubmed/32743393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12058 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|